Atorvastatin/Perindopril

阿托伐他汀/培哚普利

Report date: 2025/01/06 16:20:26

Base Information

Drug NameAtorvastatin/Perindopril
Drug Alias NameAtorvastatin+Perindopril培哚普利+阿托伐他汀培哚普利/阿托伐他汀perindopril/atorvastatinperindopril+atorvastatin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsHMG-CoA reductase inhibitors
TargetsAngiotensin-converting enzymeHMG-CoA reductase
Therapy Area/IndicationsDyslipidemiasHypertensionCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineRussian FederationGeorgia +[4] 
CombinationsYes Perindopril ArginineAtorvastatin Calcium Hydrate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesServier International Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesServier (Beijing) Pharmaceutical R&D Co Ltd
Inactive CompaniesInstitut De Recherches Internationales Servier
Active IndicationsCardiovascular Diseases
Inactive IndicationsDyslipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A